Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates
Open Access
- 15 April 2023
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 42 (4) , 112402
Abstract
No abstract availableKeywords
Funding Information
- University of Maryland
- U.S. Department of War
- U.S. Department of Health and Human Services
- NIAID (U19-AI135995, U19-AI142790)
- Defense Threat Reduction Agency (HDTRA1-15-C-0058)
- Merck
This publication has 69 references indexed in Scilit:
- Identifying human-rhesus macaque gene orthologs using heterospecific SNP probesGenomics, 2013
- Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola VirusPLOS Pathogens, 2012
- Properties of mouse and human IgG receptors and their contribution to disease modelsBlood, 2012
- Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathwayNature, 2011
- A New Ebola Virus Nonstructural Glycoprotein Expressed through RNA EditingJournal of Virology, 2011
- Ebolavirus Glycoprotein Structure and Mechanism of EntryFuture Virology, 2009
- Fcγ Receptors: Old Friends and New Family MembersImmunity, 2006
- Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functionsJournal of Clinical Investigation, 2005
- Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg virusesNature Medicine, 2005
- Pathogenesis of Experimental Ebola Zaire Virus Infection in BALB/c MiceJournal of Comparative Pathology, 2001